Sabratek's Moon Subsidary Partners With ProxyMed; OneMedPlace.com to Provide Physicians with Connections to 30,000 Pharmacies
July 15, 1999 06:59 AM
CLEARWATER, Fla. and FT LAUDERDALE, Fla., July 15 /PRNewswire/ -- Sabratek Corporation SBTK and ProxyMed, Inc., PILL announced today that Sabratek Corporation's MOON Communications subsidiary (MOON) and ProxyMed have entered into a multi-year strategic licensing agreement for the integration of ProxyNet(TM) services into the MOON web portal, OneMedPlace.com.
Under the terms of the agreement, ProxyMed has provided MOON with the source code for its proprietary drug utilization review, formulary and drug databases, as well as, access to ProxyNet, ProxyMed's online health care information network. MOON will integrate ProxyMed's electronic prescription transmission services and online healthcare information network into MOON's healthcare application services portal, OneMedPlace.com. Immediate benefits to physicians include electronic connections to over 30,000 pharmacies and online access to 93 health plan formularies. The agreement fortifies OneMedPlace.com as the premier e-commerce portal for physician information and services.
Through MOON's web-based system, physicians can determine patient eligibility, and drug formulary, and critical clinical side effect and interaction information when the prescription is written. Benefits accruing to the physician include improved quality of care and efficiencies in key areas, including processing time for medications, data transcription errors, adverse drug reactions and order duplication. OneMedPlace.com will host a number of other similar functional healthcare e-commerce solutions, enabling dramatic cost savings and improved physician practice productivity, optimizing patient care and satisfaction.
"We're pleased to have ProxyMed as our partner," said Jay Hill, CEO, MOON Communications. "The objective of OneMedPlace.com is to be the healthcare e-commerce portal of choice through preeminent clinical and financial solutions to healthcare providers. Our partnership with ProxyMed is a critical step in achieving that goal." Hill further commented, "The key to success for healthcare application service portals, is to align with the very best in each of the e-commerce sectors".
"The agreement makes perfect sense for both parties," stated Jack Guinan, Co-President of ProxyMed, Inc. "We will be the exclusive provider of electronic retail prescription services in MOON's expansive suite of connectivity solutions. MOON will be the beneficiary of years of development in our products, services and technology."
Shan Padda, Sabratek's Chief Executive Officer, said, "MOON's licensing agreement with ProxyMed represents one of several partnerships that Sabratek has recently undertaken to position OneMedPlace.com as the leading portal, providing web based clinical and financial transactions for healthcare providers and payors."
About MOON Communications
MOON Communications, Clearwater, FL, is a healthcare information services company providing an array of EDI and other clinical connectivity solutions and services through its Internet health care portal, OneMedPlace.com. Target audiences include physicians, home health agencies, payors and other key health care provider organizations.
About Sabratek
Sabratek Corporation is a clinical connectivity company consisting of eight divisions and subsidiaries. Sabratek develops, produces and markets technologically advanced, easy-to-use, smart, interactive, Web enabled medical systems that work seamlessly together to allow healthcare providers to lower costs, expand access and maintain quality across the continuum of care.
About ProxyMed
ProxyMed, Inc., based in Ft. Lauderdale, Florida, is a leading provider of internet and private network-based connectivity services. ProxyMed also provides e-commerce systems to the healthcare marketplace, including, physicians, payors, pharmacies, clinical laboratories and managed care organizations.
Note: This News Release contains "forward-looking statements" by Sabratek and ProxyMed within the meaning of the federal securities laws. These forward-looking statements include assumptions, beliefs and opinions relating to the Company's growth strategy based upon the Company's interpretation and analysis of healthcare industry trends and management's ability to successfully develop, implement, market and sell its network transaction processing services, software programs, clinical databases and financial transaction services to physicians and other healthcare providers. This strategy assumes that physicians will prefer "one-stop shopping" for its products and services and that the Company will be able to successfully develop, acquire, maintain and upgrade competitive clinical and financial transaction sets and successfully integrate them with the Company's existing products and services. This strategy also assumes that the Company will be able to successfully develop and execute its strategic relationships especially with the providers of information systems to physicians under the Company's electronic commerce partner program, and with medical laboratories, pharmacy chains, independent pharmacy owners and pharmacy information system vendors. Many known and unknown risks, uncertainties and other factors, including general economic conditions, healthcare reform initiatives, millennium compliance issues that may arise, and risk factors such as potential patent infringement claims detailed from time to time in the Company's Securities and Exchange Commission filings, may cause these forward-looking statements to be incorrect, and may cause actual results to be materially different from any future results expressed or implied by these assumptions.
SOURCE Sabratek Corporation
|
